Early pharmacological interventions on transgenic models of hypertrophic cardiomyopathy (HCM) using angiotensin receptor blockers (ARBs) may be effective in preventing development of clinical phenotype or causing phenotype regression in early stages of disease. In the clinical setting, however, the effects of ARBs on HCM phenotype have been less consistent. INHERIT (INHibition of the renin angiotensin system in hypertrophic cardiomyopathy and the Effect on hypertrophy - a Randomised Intervention Trial with losartan) was designed to assess the effect of 100 mg of losartan in promoting the regression of LV hypertrophy in HCM. The primary end-point of the study was the reduction in LV mass assessed by MRI or computed tomography. The implications of these findings are discussed in the light of further, ongoing study targeting the HCM phenotype.
INHERIT (INHibition of the renin angiotensin system in hypertrophic cardiomyopathy and the effect on hypertrophy - A randomised intervention trial with losartan) / Olivotto I., Ashley E.A.. - In: GLOBAL CARDIOLOGY SCIENCE & PRACTICE. - ISSN 2305-7823. - ELETTRONICO. - 2015:(2015), pp. 7.0-7.0. [10.5339/gcsp.2015.7]
INHERIT (INHibition of the renin angiotensin system in hypertrophic cardiomyopathy and the effect on hypertrophy - A randomised intervention trial with losartan)
Olivotto I.;
2015
Abstract
Early pharmacological interventions on transgenic models of hypertrophic cardiomyopathy (HCM) using angiotensin receptor blockers (ARBs) may be effective in preventing development of clinical phenotype or causing phenotype regression in early stages of disease. In the clinical setting, however, the effects of ARBs on HCM phenotype have been less consistent. INHERIT (INHibition of the renin angiotensin system in hypertrophic cardiomyopathy and the Effect on hypertrophy - a Randomised Intervention Trial with losartan) was designed to assess the effect of 100 mg of losartan in promoting the regression of LV hypertrophy in HCM. The primary end-point of the study was the reduction in LV mass assessed by MRI or computed tomography. The implications of these findings are discussed in the light of further, ongoing study targeting the HCM phenotype.I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.



